Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;21(11):729-738.
doi: 10.1111/hiv.13024.

Clinical epidemiology and outcome of HIV-associated talaromycosis in Guangdong, China, during 2011-2017

R S Ying  1 , T Le  2   3 , W P Cai  1 , Y R Li  4 , C B Luo  1 , Y Cao  1 , C Y Wen  1 , S G Wang  1 , X Ou  1 , W S Chen  1 , S Z Chen  1 , P L Guo  1 , M Chen  5 , Y Guo  4 , X P Tang  1 , L H Li  1
Affiliations

Clinical epidemiology and outcome of HIV-associated talaromycosis in Guangdong, China, during 2011-2017

R S Ying et al. HIV Med. 2020 Dec.

Abstract

Objectives: Talaromycosis is an invasive mycosis endemic to Southeast Asia. This study aimed to investigate the epidemiology, clinical features and prognostic factors of HIV-associated talaromycosis in Guangdong, China.

Methods: We retrospectively evaluated HIV patients hospitalized with histopathology- or culture-confirmed talaromycosis between 2011 and 2017. Factors associated with poor prognosis were identified using logistic regression.

Results: Overall, 1079 patients with HIV-associated talaromycosis were evaluated. Both the number and prevalence of talaromycosis among HIV admissions increased from 125 and 15.7% in 2011 to 253 and 18.8% in 2017, respectively, reflecting the increase in HIV admissions. Annual admissions peaked during the rainy season between March and August. Common clinical manifestations included fever (85.6%), peripheral lymphadenopathy (72.3%), respiratory symptoms (60.8%), weight loss (49.8%), skin lesions (44.5%) and gastrointestinal symptoms (44.3%). Common laboratory abnormalities were hypoalbuminaemia (98.6%), anaemia (95.6%), elevated aspartate aminotransferase level (AST) (76.9%), elevated alkaline phosphatase level (55.8%) and thrombocytopenia (53.7%). The median CD4 count was 9 cells/μL. Talaromyces marneffei was isolated from blood and bone marrow cultures of 66.6% and 74.5% of patients, respectively. The rate increased to 86.6% when both cultures were performed concurrently. At discharge, 14% of patients showed worsening conditions or died. Leucocytosis, thrombocytopenia, elevated AST, total bilirubin, creatinine and azole monotherapy independently predicted poor prognosis.

Conclusions: The incidence of HIV-associated talaromycosis has increased in Guangdong with the high HIV burden in China. Skin lesions were seen in less than half of patients. Induction therapy with azole alone is associated with higher mortality. Findings from this study should help to improve treatment of the disease.

Keywords: China; HIV; Talaromyces marneffei; penicilliosis; talaromycosis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Prevalence of HIV-associated talaromycosis among HIV admissions from 2011 to 2017.
Fig. 2
Fig. 2
Total talaromycosis (TM) case distribution by month over a 6-year period from 2011 to 2017.
See this image and copyright information in PMC

References

    1. Cao C, Xi L, Chaturvedi V. Talaromycosis (penicilliosis) due to Talaromyces (Penicillium) marneffei: insights into the clinical trends of a major fungal disease 60 years after the discovery of the pathogen. Mycopathologia 2019; 184: 709–720. - PubMed
    1. Le T, Kinh NV, Cuc NTK et al. A trial of itraconazole or amphotericin b for hiv-associated talaromycosis. N Engl J Med 2017; 376: 2329–2340. - PubMed
    1. Pruksaphon K, Intaramat A, Ratanabanangkoon K et al. Development and characterization of an immunochromatographic test for the rapid diagnosis of Talaromyces (Penicillium) marneffei. PLoS One 2018; 13: e0195596. - PMC - PubMed
    1. Lei HL, Li LH, Chen WS et al. Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, Chian. Eur J Clin Microbiol Infect Dis 2018; 37: 1099–1102. - PubMed
    1. Jiang J, Meng S, Huang S et al. Effects of Talaromyces marneffei infection on mortality of HIV/AIDS patients in southern China: a retrospective cohort study. Clin Microbiol Infect 2019; 25: 233–241. - PubMed

Publication types

Supplementary concepts